AbClon Inc. (174900.KQ)
- Previous Close
9,230.00 - Open
9,440.00 - Bid 9,590.00 x --
- Ask 9,640.00 x --
- Day's Range
9,350.00 - 10,170.00 - 52 Week Range
6,810.00 - 19,910.00 - Volume
285,016 - Avg. Volume
226,584 - Market Cap (intraday)
167.107B - Beta (5Y Monthly) 0.76
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
AbClon Inc. engages in the research and development of antibody drugs in South Korea and Sweden. The company's products in pipeline include NEST platform technology products for breast and gastric cancers; AffiMab platform technology products for colon cancer and autoimmune diseases; and CAR-T platform technology products for hematologic and ovarian cancers. AbClon Inc. was founded in 2010 and is based in Seoul, South Korea.
www.abclon.comRecent News: 174900.KQ
View MorePerformance Overview: 174900.KQ
Trailing total returns as of 4/23/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 174900.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 174900.KQ
View MoreValuation Measures
Market Cap
160.83B
Enterprise Value
156.66B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
65.95
Price/Book (mrq)
5.55
Enterprise Value/Revenue
66.96
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-20.81%
Return on Equity (ttm)
-57.57%
Revenue (ttm)
2.34B
Net Income Avi to Common (ttm)
-16.3B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
21.86B
Total Debt/Equity (mrq)
58.67%
Levered Free Cash Flow (ttm)
-12.58B